Business
Establishment Labs® Announces Meghan Trainor as Brand Partner Following Her Breast Augmentation with Motiva Implants®
The campaign is the first-of-its-kind partnership and follows the US FDA approval of Motiva Implants® NEW YORK, March 6, 2025 /PRNewswire/ -- Establishment
About this update from Establishment Labs Holdings Inc.
[{"type":"text","content":"The campaign is the first-of-its-kind partnership and follows the US FDA approval of Motiva Implants® \nNEW YORK, March 6, 2025 /PRNewswire/ -- Establishment Labs® Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced a partnership with GRAMMY Award-winning hitmaker Meghan Trainor. Meghan recently received Motiva Implants® after careful consideration and research.\n\n \n \n\n \n\"Self-confidence and body positivity are so important to me. After losing a bunch of weight and having two kids, I have always struggled loving my breasts because they were never even. I've been dreaming about getting this done for so many years. Once I learned about the recent FDA approval of Motiva Implants®, I knew this was the perfect time for me,\" Meghan shared. \"I did my research, consulted with several plastic surgeons, and chose Motiva Implants® because they offered the look, the smooth silk feel, and the safety I was looking for. There is just such a difference with these new generation implants. I'm absolutely in love with the results — they feel so soft and natural and I'm more confident than ever. I can't wait to get back on stage with so many new outfit choices.\"\nMotiva Implants® represent state-of-the-art innovation in plastic surgery. These implants, available to patients in the US since October 2024, feature the patented SmoothSilk® surface, designed for enhanced biocompatibility and scientifically shown to promote low inflammation1. This surface not only helps the tissue around the implant to stay soft1, but also has led to an industry low 0.5% capsular contracture rate2. Motiva SmoothSilk Ergonomix® implants are unique as their shape adapts as the body changes position, maintaining a round shape when lying down and a teardrop shape when standing up3,4,5. Motiva SmoothSilk® Round implants provide increased upper breast fullness and softness3,4,6 while keeping a round full form regardless of position. Both the Motiva SmoothSilk Ergonomix® and the Motiva SmoothSilk® Round implants were designed to provide the look and natural feel women want with the safety profile they deserve. Motiva® devices, through FDA clinical studies, have reported less than 1% device related complications2, and above 97% patient a...